BMS’ Plaque Psoriasis Drug Deucravacitinib Among Six Hopefuls Awaiting EMA Verdict

 
• By Vibha Sharma
  
Concept of EMA European Medicines Agency. Drugs evaluation and quality control.
Companies Could Soon Learn If Their Products Have Won The EMA’s Backing • Source: Shutterstock

More from Approvals

More from Product Reviews